Indoco Remedies Share Price
262.51-10.05 (-3.69%)
-6.83% past 1 Year
Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under the provision of the Companies Act, VII of 1913. Indoco Remedies Limited is engaged in the
Corporate filings & documents
Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Panandikar & Others
1 day agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Panandikar & Others
1 day agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
3 days agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
3 days agoIntimation of execution of Deed of Conveyance for Sale of Companys plot of land.
1 week agoIntimation of execution of Deed of Conveyance for Sale of Companys plot of land.
1 week agoNewspaper Advertisement-Information regarding 79th Annual General meeting and E-voting
1 week agoNewspaper Advertisement-Information regarding 79th Annual General meeting and E-voting
1 week agoBusiness Responsibility and Sustainability Reporting (BRSR)
2 weeks agoBusiness Responsibility and Sustainability Reporting (BRSR)
2 weeks agoAnnual Report for the financial year 2025-2026
2 weeks agoAnnual Report for the financial year 2025-2026
2 weeks agoNotice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026
2 weeks agoNotice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026
2 weeks agoNotice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026
2 weeks agoNotice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026
2 weeks agoIntimation of Cut-Off Date for E voting Book Closure and Record date for Dividend
2 weeks agoIntimation of Cut-Off Date for E voting Book Closure and Record date for Dividend
2 weeks agoPublication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September 2026 through VC/OAVM
2 weeks agoPublication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September 2026 through VC/OAVM
2 weeks agoTranscript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026
1 month agoTranscript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026
1 month agoPublication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoPublication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoAudio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoAudio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoThe Board of Directors in its Meeting held today i.e. 28th July 2026 has considered and approved1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February 2027 to 14th February 2032 subject to the approval of the shareholders in the ensuing AGM.2. Appointment of Mr. Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company w.e.f. 28th July 2026
1 month agoThe Board of Directors in its Meeting held today i.e. 28th July 2026 has considered and approved1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February 2027 to 14th February 2032 subject to the approval of the shareholders in the ensuing AGM.2. Appointment of Mr. Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company w.e.f. 28th July 2026
1 month agoUnaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with Limited Review Report
1 month agoUnaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with Limited Review Report
1 month agoPursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 28th July 2026 has inter-alia considered and approved Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.
1 month agoPursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 28th July 2026 has inter-alia considered and approved Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.
1 month agoIntimation of Earnings Conference Call on Unaudited Financial Results for Quarter ended 30th June 2026
1 month agoIntimation of Earnings Conference Call on Unaudited Financial Results for Quarter ended 30th June 2026
1 month agoIndoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended 30th June 2026.
1 month agoIndoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended 30th June 2026.
1 month agoAttached the certificate issued by MUFG Intime India Private Limited Registrar & Transfer Agent of the Company confirming compliance under Reg 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended 30-06-2026
1 month agoAttached the certificate issued by MUFG Intime India Private Limited Registrar & Transfer Agent of the Company confirming compliance under Reg 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended 30-06-2026
1 month agoIntimation regarding Closure of Trading Window
2 months agoIntimation regarding Closure of Trading Window
2 months agoPress Release : Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
2 months agoPress Release : Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
2 months agoNotice for transfer of equity shares of the Company to the Investor Education and Protection Fund ("IEPF")
2 months agoNotice for transfer of equity shares of the Company to the Investor Education and Protection Fund ("IEPF")
2 months agoIndocos formulation plant at Baddi (Plant III) receives EU GMP Certification
3 months agoEnclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe Proprietor of M/s. A.Y.Sathe & Co Company Secretaries.
3 months agoEnclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe Proprietor of M/s. A.Y.Sathe & Co Company Secretaries.
3 months agoIntimation regarding completion of transfer of Ophthalmic Division of the Company to Sunways (India) Private Limited
3 months agoIntimation regarding completion of transfer of Ophthalmic Division of the Company to Sunways (India) Private Limited
3 months agoThe Company hereby regrets to inform about the sad demise of Dr. Anand Nadkarni (DIN : 06881461) Non Executive Director of the Company today i.e. Friday 15th May 2026.
3 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
Jul 2024
ConcallPresentation
May 2024
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Jul 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-10
Dividend
0.2
2025-09-04
Dividend
0.2
2024-09-19
Dividend
1.5
2023-09-18
Dividend
2.25
2022-09-14
Dividend
2.25
2021-09-17
Dividend
1.5
2020-09-18
Dividend
0.3
2019-08-22
Dividend
0.3
2018-08-31
Dividend
1.0
2017-07-31
Dividend
1.6
2016-07-20
Dividend
0.2
2016-03-17
Dividend
1.4
2015-07-21
Dividend
1.6
2014-07-21
Dividend
1.4
2013-07-19
Dividend
1.1
2012-07-20
Dividend
1.1
2011-07-19
Dividend
8.0
2010-07-13
Dividend
7.0
Company details
Registered office
Indoco House 166 C S T Road Kalina , Santacruz (East) Mumbai Maharashtra PIN: 400098 Tel No: 022-62871000 / 68791250 Fax No: 022-26520787 Email: [email protected] Internet: www.indoco.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Ramanathan Hariharan, Company Secretary & Compliance Officer, Head- Legal
Suresh G Kare, Chairman
Aditi Panandikar, Managing Director
Sundeep V Bambolkar, Joint Managing Director
Abhijit Y Gore, Non Executive Independent Director
Vasudha V Kamat, Non Executive Independent Director
Ajay Mulgaokar, Non Executive Independent Director
Satish Shenoy, Non Executive Independent Director
Details
BSE 532612
NSE INDOCO
ISIN INE873D01024